Zobrazeno 1 - 10
of 10
pro vyhledávání: '"April Trebnick"'
Autor:
Matthew R. Reynolds, Julie P Sutherland, Emily A Tucker, C. Michael Valentine, Fran Thorpe, Clifford Ehrlich, Christopher P. Cannon, Steven E. Hearne, Sara Jaffer, Gheorghe Doros, Matthew A. Cavender, Sudarshana Datta, April Trebnick, Yang Song, Joseph Kim, Nasser Smiley, Ravinder Bachireddy, Jane J. Lee
Publikováno v:
Journal of the American College of Cardiology. 77:1809
Autor:
Harshali K. Patel, Yang Song, Christopher P. Cannon, Gheorghe Doros, April Trebnick, Hanna K. Gaggin, Nasrien E. Ibrahim, Juan Maya, Alexander Turchin, James L. Januzzi
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy. 5(1)
Aims High resting heart rate (HR ≥70 b.p.m.) is associated with worse clinical outcomes in heart failure with reduced ejection fraction (HFrEF). Heart rate, guideline-directed medical therapy (GDMT) with beta-blocker (BB), and cardiovascular outcom
Autor:
Angelo Ponirakis, Nasrien E. Ibrahim, Patricia A. Russo, April Trebnick, Gheorghe Doros, Claire Alexanian, James L. Januzzi, Christopher P. Cannon, Yang Song
Publikováno v:
International journal of cardiology. 254
Autor:
Thomas J. Wang, Asya Lyass, Ralph B. D'Agostino, Joseph M. Massaro, James L. Januzzi, April Trebnick, Yuyin Liu, Ramachandran S. Vasan, Alan S. Maisel, Hanna K. Gaggin
Objective— Neurotensin is a peptide whose receptor (sortilin receptor 1) is linked to cardiovascular disease (CVD) development. We hypothesized concentrations of proneurotensin (stable profragment of neurotensin) would predict incident cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a80bc586448c9c7a0b865b7a4591711c
https://europepmc.org/articles/PMC4965295/
https://europepmc.org/articles/PMC4965295/
Autor:
Gheorghe Doros, Angelo Ponirakis, James L. Januzzi, Christopher P. Cannon, Nasrien E. Ibrahim, Yang Song, Claire Alexanian, April Trebnick, Patricia A. Russo
Publikováno v:
International Journal of Cardiology. 254:R1
Autor:
James Januzzi, Asya Lyass, Yuyin Liu, Hanna K Gaggin, April Trebnick, Ralph B D'Agostino, Thomas J Wang, Joseph Massaro, Vasan Ramachandran
Publikováno v:
Circulation. 132
Introduction: Neurotensin is a 13-amino acid peptide whose receptor (SORT1) is strongly linked to cardiovascular disease (CVD) development through several mechanisms, including a role in hepatic low density lipoprotein (LDL) metabolism. We measured c
Autor:
Gheorghe Doros, Yang Song, April Trebnick, Christopher P. Cannon, Angelo Ponirakis, Patricia A. Russo, Nasrien E. Ibrahim, James L. Januzzi, Claire Alexanian
Publikováno v:
Journal of Cardiac Failure. 23:S51
Autor:
Angelo Ponirakis, Patricia A. Russo, Yang Song, April Trebnick, Nasrien E. Ibrahim, Christopher P. Cannon, Gheorghe Doros, Claire Alexanian, James L. Januzzi
Publikováno v:
Journal of Cardiac Failure. 23:S51
Autor:
James L. Januzzi, Yang Song, Gheorghe Doros, Nasrien E. Ibrahim, Alexander Turchin, April Trebnick, Hanna K. Gaggin, Juan M Maya, Harshali Patel, Christopher P. Cannon
Publikováno v:
Journal of the American College of Cardiology. 69:729
Autor:
Christopher J. O'Donnell, Asya Lyass, Joseph M. Massaro, James L. Januzzi, Vasan Ramachandran, Ralph B. D'Agostino, Thomas J. Wang, April Trebnick, Hanna K. Gaggin
Publikováno v:
Journal of the American College of Cardiology. 67:1903
Neurotensin is a peptide with a wide range of cardiovascular (CV) effects. We recently reported that blood concentrations of pro-neurotensin (pro-NT; the stable pro-fragment of neurotensin) are associated with incident CV events in the community. We